Table: begin end state 1 32 cytoplasmic 33 56 transmembrane 57 61 non-cytoplasmic 62 84 transmembrane 85 104 cytoplasmic 105 128 transmembrane 129 166 non-cytoplasmic 167 185 transmembrane 186 196 cytoplasmic 197 216 transmembrane 217 236 non-cytoplasmic 237 259 transmembrane 260 273 cytoplasmic 274 294 transmembrane 295 324 non-cytoplasmic 325 344 transmembrane 345 374 cytoplasmic 375 392 transmembrane 393 397 non-cytoplasmic 398 418 transmembrane 419 430 cytoplasmic 431 449 transmembrane 450 454 non-cytoplasmic 455 473 transmembrane 474 484 cytoplasmic
Input: >WP_025765060.1 NCBI__GCF_000566685.1:WP_025765060.1 MASQLWFKKPIEKLLQESTGEENQLKRSLSSLSLVALGIGAIIGAGLFSLTGIAAAEHSG PAVTISFIVAAVGCGFAGLCYAEFASMIPIAGSAYTYSYATMGEFVAWIIGWDLVLEYAL GAATVSVSWSRYLLEFLSKFDIHLPTQLVSSPFEVLTLSDGTIIDNGIINLPAILIVWML SLLLIRGTEGSAYLNNFLVILKVAVVLIFIGLGWSHINPENYVPYIPENTGNYENFGWSG IATGAAVVFFAFIGFDAVSTAAQEAKNPQKGMPIGILGSLIVCTILYVLFAHVMTGLVNY KEFANDAKPAATAFAATGYDSLQTGLIVAILAGYTSVMLVMLLGQSRVFYSMSKDGLLPK FFSEIHPKFSTPWKTNIFFMLFVSIFAGFVPVSDLGHMVSIGTLFAFSLVCVGVWMLRVK RPDLPRSFRTPLVPFVPLMGIIVCVYLMYSLPIESWYRLAIWLALGLAIYFFYGKKNSKL GKEQ
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server